FilingSEC EDGAR8-K
Celularity Enters Exclusive Manufacturing Collaboration with Vesalius for Peptide APIs
· SEC accepted
StageAgreement Signed
Filing content
Celularity has entered into an exclusive manufacturing agreement with Vesalius Longevity Labs to produce Peptual-branded peptide APIs in the U.S. Celularity will utilize its New Jersey facility for purification and manufacturing activities.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…